Mark W. Feinberg

9.5k total citations · 2 hit papers
127 papers, 7.3k citations indexed

About

Mark W. Feinberg is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mark W. Feinberg has authored 127 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 50 papers in Cancer Research and 33 papers in Immunology. Recurrent topics in Mark W. Feinberg's work include Cancer-related molecular mechanisms research (35 papers), MicroRNA in disease regulation (32 papers) and Circular RNAs in diseases (23 papers). Mark W. Feinberg is often cited by papers focused on Cancer-related molecular mechanisms research (35 papers), MicroRNA in disease regulation (32 papers) and Circular RNAs in diseases (23 papers). Mark W. Feinberg collaborates with scholars based in United States, China and Spain. Mark W. Feinberg's co-authors include Xinghui Sun, Kathryn J. Moore, Basak Icli, Akm Khyrul Wara, Stefan Haemmig, Zhiyong Lin, Mukesh K. Jain, Viorel Simion, Nathan Belkin and Ajay Kumar and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Mark W. Feinberg

125 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation

2004 564 citations Mark W. Feinberg, Daniel I. Simon et al. profile →
MicroRNA Regulation of Atherosclerosis

2016 495 citations Mark W. Feinberg et al. profile →

Peers

Countries citing papers authored by Mark W. Feinberg

Since Specialization

Citations

This map shows the geographic impact of Mark W. Feinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Feinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Feinberg more than expected).

Fields of papers citing papers by Mark W. Feinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Feinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Feinberg. The network helps show where Mark W. Feinberg may publish in the future.

Co-authorship network of co-authors of Mark W. Feinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Feinberg. A scholar is included among the top collaborators of Mark W. Feinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Feinberg. Mark W. Feinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling 2025 ·Journal of Clinical Investigation ·Ming Zhai, (unknown), Jun Qian, Winona Wu, (unknown), Vinay Randhawa, (unknown), Arvind K. Pandey, Akm Khyrul Wara, (unknown), Yi Hu, Jéssica Leite Garcia, (unknown), Terence E. Ryan, Wenhui Peng, Mark W. Feinberg	0
2	Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease 2024 ·Journal of Vascular Surgery ·(unknown), (unknown), Laura Newton, (unknown), Jialin Mao, Weiping Zhou, (unknown), (unknown), Mark A. Eid, Kayla Moore, David G. Armstrong, Mark W. Feinberg, Marc P. Bonaca, Mark A. Creager, Philip P. Goodney	3
3	Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy 2024 ·Diabetes Obesity and Metabolism ·Filipe A. Moura, Andrea Bellavia, David D. Berg, Giorgio Melloni, Mark W. Feinberg, Lawrence A. Leiter, Erin A. Bohula, David A. Morrow, (unknown), Stephen D. Wiviott, Marc S. Sabatine	1
4	TEAD1‐Mediated Trans‐Differentiation of Vascular Smooth Muscle Cells into Fibroblast‐Like Cells Contributes to the Stabilization and Repair of Disrupted Atherosclerotic Plaques 2024 ·Advanced Science ·Ming Zhai, Zhijun Lei, (unknown), (unknown), Yanxi Zeng, (unknown), Weixia Jian, Jianhui Zhuang, Qing Yu, Mark W. Feinberg, Wenhui Peng	2
5	Electrostatically assembled wound dressings deliver pro-angiogenic anti-miRs preferentially to endothelial cells 2023 ·Biomaterials ·Adam G. Berger, (unknown), (unknown), Michael McCoy, Sarah Ameen Almofty, Mark W. Feinberg, Paula T. Hammond	12
6	Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019 2023 ·Circulation Cardiovascular Quality and Outcomes ·(unknown), Mark A. Eid, Jonathan Barnes, (unknown), Andrea M. Austin, (unknown), Kayla Moore, Stephen Kearing, Mark W. Feinberg, Marc P. Bonaca, Mark A. Creager, Philip P. Goodney	11
7	FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis—Brief Report 2023 ·Arteriosclerosis Thrombosis and Vascular Biology ·Aspasia Tzani, Stefan Haemmig, Henry S. Cheng, Daniel Pérez‐Cremades, (unknown), (unknown), Sasha A. Singh, Masanori Aikawa, Paul B. Yu, (unknown), Ye Sun, Mark W. Feinberg, Jorge Plutzky	2
8	A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia 2023 ·JCI Insight ·Henry S. Cheng, Rulin Zhuang, Daniel Pérez‐Cremades, Jingshu Chen, (unknown), Winona Wu, Grasiele Sausen, Aspasia Tzani, Jorge Plutzky, Jorge Henao‐Mejia, Philip P. Goodney, Mark A. Creager, Marc S. Sabatine, Marc P. Bonaca, Mark W. Feinberg	9
9	Dysregulated Genes, MicroRNAs, Biological Pathways, and Gastrocnemius Muscle Fiber Types Associated With Progression of Peripheral Artery Disease: A Preliminary Analysis 2022 ·Journal of the American Heart Association ·Sunil Saini, Daniel Pérez‐Cremades, Henry S. Cheng, Kate Kosmac, Charlotte A. Peterson, Lingyu Li, Lü Tian, (unknown), Kevin C.‐W. Wu, (unknown), Stephanie E. Wohlgemuth, Terence E. Ryan, Robert Sufit, Luigi Ferrucci, Mary Mcdermott, Christiaan Leeuwenburgh, Mark W. Feinberg	8
10	Isolation and culture of murine aortic cells and RNA isolation of aortic intima and media: Rapid and optimized approaches for atherosclerosis research 2022 ·Atherosclerosis ·Jingshu Chen, Rulin Zhuang, Henry S. Cheng, (unknown), (unknown), Michael McCoy, Shruti Rawal, Daniel Pérez‐Cremades, Mark W. Feinberg	12
11	Deficiency of lncRNA SNHG12 impairs ischemic limb neovascularization by altering an endothelial cell cycle pathway 2021 ·JCI Insight ·David A. Gross, Henry S. Cheng, Rulin Zhuang, Michael McCoy, Daniel Pérez‐Cremades, Zachary R. Salyers, Akm Khyrul Wara, Stefan Haemmig, Terence E. Ryan, Mark W. Feinberg	13
12	Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans 2021 ·Arteriosclerosis Thrombosis and Vascular Biology ·Stefan Haemmig, Ali Hashemi Gheinani, Marina Zaromytidou, Gerasimos Siasos, Ahmet U. Coskun, (unknown), David A. Gross, Akm Khyrul Wara, Antonios P. Antoniadis, Xinghui Sun, Galina K. Sukhova, (unknown), Ioannis Andreou, Carl Whatling, Li‐Ming Gan, Johannes Wikström, Elazer R. Edelman, Peter Libby, Peter H. Stone, Mark W. Feinberg	3
13	LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling 2020 ·JCI Insight ·Viorel Simion, Haoyang Zhou, Jacob B. Pierce, Dafeng Yang, Stefan Haemmig, Yevgenia Tesmenitsky, Galina K. Sukhova, Peter H. Stone, Peter Libby, Mark W. Feinberg	61
14	MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities 2018 ·Trends in Cardiovascular Medicine ·Denizhan Ozdemir, Mark W. Feinberg	56
15	miRNAs in atherosclerotic plaque initiation, progression, and rupture 2015 ·DSpace@MIT (Massachusetts Institute of Technology) ·Ioannis Andreou, Xinghui Sun, Peter H. Stone, Elazer R. Edelman, Mark W. Feinberg	4
16	Endothelial MicroRNAs and Atherosclerosis 2013 ·Current Atherosclerosis Reports ·Xinghui Sun, Nathan Belkin, Mark W. Feinberg	115
17	Abstract 15820: S-Nitrosoglutathione Reductase (GSNOR) Modulates Reendothelialization and Vascular Repair 2011 ·Circulation ·André Manica, Júlio Flávio Meirelles Marchini, Richard J. Travers, Yevgenia Tesmenitsky, Akm Khyrul Wara, (unknown), Mark W. Feinberg, Jonathan S. Stamler, Daniel I. Simon, Kevin Croce	1
18	Kruppel-like Factor KLF10 Targets Transforming Growth Factor-β1 to Regulate CD4+CD25− T Cells and T Regulatory Cells 2009 ·Journal of Biological Chemistry ·Zhuoxiao Cao, Akm Khyrul Wara, Basak Icli, Xinghui Sun, René R. Sevag Packard, Fehim Esen, Christopher J. Stapleton, Malayannan Subramaniam, Karsten Kretschmer, Irina Apostolou, Harald von Boehmer, Göran K. Hansson, Thomas C. Spelsberg, Peter Libby, Mark W. Feinberg	80
19	Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages 2000 ·Journal of Biological Chemistry ·(unknown), Mark W. Feinberg, (unknown), Nicholas Sibinga, Philippe Wiesel, Hong Wang, James N. Topper, Mark A. Perrella, Mu-En Lee	143
20	Donor MHC and adhesion molecules in transplant arteriosclerosis 1999 ·Journal of Clinical Investigation ·(unknown), Mark W. Feinberg, Dorothy Zhang, Anand Patel, Choon Boon Sim, Zhao Dong, (unknown), José-Carlos Gutierrez-Ramos, Denisa D. Wagner, Nicholas Sibinga, Edgar Haber	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact